Small Cap Feast

Small Cap Feast – 15 August 2019

Dish of the Day:

No Joiners Today

Off the Menu:

Tarsus Group (TRS) – Tarsus has been removed from the main market  following an all cash offer for 425p per share.

What’s Cooking in the IPO Kitchen?

Breakfast Buffet

Thor Mining PLC* (THR) 0.72p £5.34m

The Board of Thor Mining Plc announced an initial Mineral Resource Estimate (MRE) containing 114,000 tonnes of copper, considered amenable to In Situ Recovery techniques (“ISR”), released 15 August 2019 by EnviroCopper Ltd..

Thor, as announced on 5 March 2019, is acquiring up to a 30% interest in EnviroCopper, which in turn is earning from Andromeda Metals Limited (ASX: ADN) up to a 75% interest in the mineral rights and claims over the northern portion of the Moonta exploration licence area (EL5984) in South Australia.

EnviroCopper Ltd are also earning, from Terramin Australia Limited (ASX:TZN), up to a 75% interest in the mineral rights and claims over the portion of the historic Kapunda copper mine in South Australia recoverable by way of in situ recovery techniques

Subject to full earn in Thor would therefore hold an effective 22.5% interest in each of the Moonta and Kapunda copper projects.

Tissue Regenix Group (TRX) 3.85p £45.12m

Tissue Regenix Group the regenerative medical devices company, announces that it has signed a 10-year lease agreement on a 21,000 sq. ft. facility to expand processing capacity at its manufacturing base in San Antonio, Texas. The agreement also includes the option to purchase the facility at a later date. 

The new facility, situated on adjacent land to the Group’s current 13,700 sq. ft. facility, will be brought on stream in a phased plan to meet the growing commercial demand for the Company’s novel product portfolio. Phase one will commence immediately with part of the new building being converted into office, distribution and warehouse space, allowing for additional clean rooms to be built in the original facility, which are expected to be operational by the end of H1 2020.

Over time, it is planned for further processing and packaging clean rooms to be built in the new facility therefore, increasing the Company’s ability to process more tissue and produce products. The new facility underpins the Company’s strategy of building strategic partnerships, accelerating US market penetration and pursuing geographic expansion opportunities.

Kibo Energy PLC (KIBO) 0.95p £6.59m

Kibo Energy PLC, the multi-asset, Africa focused, energy company, announced that it has been granted seven Mining Rights for its Mbeya Coal to Power Project (‘MCPP’) in Tanzania, further to the announcement dated 9 July 2019.

The Company continues to advance the MCPP in Tanzania, one of its four international power projects, which the board believes represents an exciting opportunity. Accordingly, the application process for seven Mining Licences covering the original Special Mining Licence (‘SML’) application area has been completed by the Mining Commission, and an Offer Letter for each application has been issued to Kibo’s 100% owned subsidiary, Mbeya Coal Ltd, each of which it has subsequently accepted.  This constitutes approval and grant of the Mining License applications, subject to Kibo remitting all required statutory payments related to the issuance of a Mining Right.

The MCPP has a 120.8 Mt NI 43 101 thermal Coal Resource covered by the seven Mining Licences now granted. A Definitive Feasibility Study confirmed the economic viability of the mining project with an indicated IRR of 69.2%.  Grant of the Mining Rights will enable commercial mining activity to commence

Vianet Group PLC (VNET) 119.50p £33.62m

Vianet Group plc the international provider of actionable data and business insight through devices connected to its Internet of Things (“IOT”) platform, today provides the following business update.

Trading for the first four months of 2020 financial year has been as anticipated with the Group being on course to meet market expectations.

The Group’s Smart Machines division has successfully concluded negotiations on three long-term contracts with leading vending operators.  The combined contracts for 20,000 units will generate in the region of £10m of revenue over the three to five year contract terms, which further underpins the growth of Smart Machines.

Craig Brocklehurst, currently Commercial Operations Director, has been appointed to head up the Group’s Smart Zones division.  This follows the forthcoming departure of Steve Alton who was recently appointed Chief Executive of pub industry body, the British Institute of Innkeeping.

Altus Strategies PLC (ALS) 4.75p £8.45m

Altus Strategies Plc the Africa focused project and royalty generator, announces the discovery of multiple hard rock gold workings at its 100% owned, 285km2 Zager exploration licence which is targeting Volcanogenic Massive Sulphide gold deposits in the Tigray National Regional State of northern Ethiopia.


Hard rock gold workings discovered at recently granted Zager licence

Project located within the highly prospective geology of the Arabian Nubian shield

Numerous geophysical anomalies delineated with one coincident with a hard rock working

Priority targets identified along strike of known deposits on an adjacent mining licence

Licence wide stream sediment sampling programme underway

Phoenix Global Res (PGR) 16.4p £456.74m

Phoenix Global Resources plc, the upstream oil and gas company offering its investors direct exposure to Argentina’s Vaca Muerta shale formation and other unconventional resources, announced the initial crude oil production from its first horizontal muti-fractured wells at the Mata Mora concession in the Neuquén province.

During the month of July 2019, a total of 34,273 barrels of Mata Mora light crude with API gravity of 36 degrees representing the initial test volumes was produced from the two Mata Mora lateral wells. Both Mata Mora wells were drilled earlier in the year and were unconventionally completed in the La Cocina horizon of the Vaca Muerta formation in June 2019.

Oakley Capital Inv. (OCI) 225p £459.90m

Oakley Capital Investments Limited announced that Oakley Capital IV2 has agreed to acquire a majority stake in Seven Miles GmbH  partnering with its founders, Tom Schröder and Valentin Schütt.

Seven Miles is based in Germany and is a leading consumer technology company in the gift voucher and B2B gift card sector. Since it was founded in 2014, the business has grown rapidly to become one of the leading physical and digital gift card networks in the DACH region. In 2019, Seven Miles expects to sell gift solutions in excess of €100m, following very strong growth. The market for multi-brand gift cards in Germany is expected to grow at over 15% in the coming years, as consumers increasingly value the convenience and flexibility that make gift cards an attractive present for many occasions.

Jangada Mines PLC (JAN) 0.95p £2.31m

Jangada Mines plc, a natural resources company, announced that, further to its announcement on 2 August 2019, the remaining Conditions have been satisfied and, as such, the agreement to dispose of Pedra Branca Brasil Mineracao Ltda., the entity that holds the Pedra Branca Project, to ValOre, as set out in the circular posted to Shareholders on 17 July 2019, completed on 14 August 2019 .

Accordingly, the Company has formally transferred ownership of Pedra Branca Brasil Mineracao Ltda. to PBBM Holdings Ltd., a wholly owned subsidiary of ValOre, in consideration for the issuance of 22,000,000 ValOre common shares to Jangada and receipt by Jangada of the first tranche of cash proceeds in the amount of C$750,000. Following the issuance of the Initial Consideration Shares, Jangada will have a holding of 26 per cent in ValOre’s then enlarged share capital.

Keras Resources PLC (KRS) 0.49p £11.45m

Keras Resources plc, the AIM listed mineral resource company, notes the announcement published today by Calidus Resources Limited (ASX:CAI), in which it currently holds a c.38.9% interest, regarding Calidus’ recently completed AUD$9m placement involving institutional shareholders. Keras did not participate in the placement. Following the allotment and commencement of trading of the new shares in Calidus on or around 20 August 2019, Keras will hold a c.33.8% interest in Calidus.

Inspiration Health (IHC) 63p £19.32m

Inspiration Healthcare Group plc, the global medical technology company, gave a trading update for the six months ended 31 July 2019.

As was announced to shareholders in the statement given at the Annual General Meeting on 27 June 2019, the current year has started well. The Board anticipates that the results for the six months to 31 July 2019 will be in line with expectations and that the Company will achieve double-digit growth over the full year.

Head Chef:

Derren Nathan
0203 764 2344

*A corporate client of Hybridan LLP


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.